DSD-T345

Congenital adrenal hyperplasia (CAH) · 46,XY · DSD-T345

DSD-T345 · Congenital adrenal hyperplasia (CAH) · 2023 · Automated translation

Genes AR · Karyotype 46,XY

Suspected 17α-hydroxylase deficiency (partial form, a rare form of 46,XX DSD/CAH) with autoimmune adrenalitis, presenting as primary infertility.

Case fields and evidence

Category

Congenital adrenal hyperplasia (CAH)

Karyotype

46,XY

Genetics

AR

Diagnosis

Suspected 17α-hydroxylase deficiency (partial form, a rare form of 46,XX DSD/CAH) with autoimmune adrenalitis, presenting as primary infertility.

Follow-up

Delivered two healthy female infants at term; 1 year postpartum, blood pressure normal, menses regular, adrenal atrophy, and 21-hydroxylase antibodies elevated.

General phenotype

Female phenotype, no abnormal clinical findings, no hyperandrogenism, no hypertension or hypokalemia.

Imaging

Transvaginal ultrasound: normal uterus, proliferative-phase endometrium, antral follicle count 9, dominant follicle seen on day 12; hysterosalpingo-contrast sonography showed left tubal obstruction; adrenal CT showed 5/5 mm and 9/6 mm nodules in the right adrenal gland (possible adenomas), and postpartum follow-up showed adrenal atrophy; breast ultrasound normal.

Laboratory findings

Early follicular 17-OHP 12.3–15.6 ng/mL (normal 0.1–0.8); cortisol 5.68 μg/dL (5–25), ACTH >2000 pg/mL (7.2–63.3); total testosterone 6.38 ng/mL (8.4–48.31, low), DHEAS 6.3 μg/dL (98.8–340, low); 11-deoxycorticosterone 0.26 μg/L (<0.16, mildly elevated); aldosterone 1.92 ng/dL (2.52–39.2) and direct renin 2 μIU/mL (4.4–46.1), both decreased; FSH 7.42 mIU/mL, LH 8.32 mIU/mL, E2 144.4 pg/mL; serum sodium 130 mmol/L, serum potassium 4.6 mmol/L; TSH 2.49 μIU/mL, FT4 1.44 ng/dL; AMH 0.74 ng/mL; 250 μg Synacthen test: cortisol 5.35 μg/dL, 17-OHP 12.92 ng/mL, 11-DOC 0.36 μg/L; 21-hydroxylase antibody 66.3 (<10).

Management

Hydrocortisone 25 mg/day orally for 2 months (ACTH decreased to 370 pg/mL, progesterone remained 1.8 ng/mL); switched to dexamethasone 0.75 mg/day, after which progesterone normalized (0.21 ng/mL); GnRH agonist 3.75 mg for downregulation, estradiol 6 mg/day for endometrial preparation, vaginal progesterone 600 mg/day, and frozen-thawed blastocyst transfer; hydrocortisone 25 mg/day during pregnancy.

Pathology

Not reported in the original article

Evidence level

See source

Clinical history

See source

Family history

See source

Growth and development

See source

External genital examination

See source

Puberty / Tanner

See source

Cite this resource

DSD Research Library | Congenital adrenal hyperplasia (CAH) · 46,XY · DSD-T345 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T345?version=v1.4.0